Jessica C. Hassel
Heidelberg, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 356 publications
Neoadjuvant Intralesional Daromun (L19IL2/L19TNF) in Resectable Locally Advanced Melanoma: An Update on the Efficacy and Safety Results of the PIVOTAL Phase III Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 11, 2026
Hierarchical classification of immune cell transcriptomes at population-scale.
Journal: bioRxiv : the preprint server for biology
Published: June 12, 2026
Hierarchical classification of immune cell transcriptomes at population-scale.
Journal: bioRxiv : the preprint server for biology
Published: June 12, 2026
Immune checkpoint inhibitor therapy after tumor-infiltrating lymphocytes in unresectable melanoma.
Journal: Journal for immunotherapy of cancer
Published: June 10, 2026
Baseline dual-energy CT iodine uptake predicts systemic but not lesion-level progression in immunotherapy-treated metastatic melanoma.
Journal: European journal of radiology
Published: June 02, 2026
Activated charcoal filtration profoundly alters systemic noradrenaline concentrations during hepatic chemosaturation: A prospective cohort study.
Journal: PloS one
Published: April 14, 2026
Are liver metastases from uveal melanoma a clinical indication for dynamic PET? A comparison of Patlak parametric imaging with standard and delayed static SUV imaging using long axial field-of-view PET/CT.
Journal: European journal of nuclear medicine and molecular imaging
Published: April 08, 2026
Plain language summary of the LOGIC 2 study: Encorafenib, binimetinib, plus a third drug for people with BRAF V600-mutant melanoma.
Journal: Future oncology (London, England)
Published: March 31, 2026
Therapy of melanoma : Current standards and future perspectives
Journal: Pathologie (Heidelberg, Germany)
Published: March 30, 2026
Beyond target lesions: Prognostic value of longitudinal AI-derived whole-body [1⁸F]FDG PET/CT metrics in metastatic melanoma.
Journal: European journal of nuclear medicine and molecular imaging
Published: March 18, 2026
Five-year survival with tebentafusp in metastatic uveal melanoma.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: March 02, 2026
Re-Exposure of a PD-1 Inhibitor After Previous Immune-Related Adverse Events.
Journal: Current oncology (Toronto, Ont.)
Published: February 26, 2026
Last Updated: 09/26/2026